Literature DB >> 35668221

Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Reply of the Editor in Chief.

Giuseppe Citerio1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35668221     DOI： 10.1007/s00134-022-06758-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  6 in total

1.  Correction to: Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.

Authors:  Adrien Bouglé; Sophie Tuffet; Laura Federici; Marc Leone; Antoine Monsel; Thomas Dessalle; Julien Amour; Claire Dahyot-Fizelier; François Barbier; Charles-Edouard Luyt; Olivier Langeron; Bernard Cholley; Julien Pottecher; Tarik Hissem; Jean-Yves Lefrant; Benoit Veber; Matthieu Legrand; Alexandre Demoule; Pierre Kalfon; Jean-Michel Constantin; Alexandra Rousseau; Tabassome Simon; Arnaud Foucrier
Journal:  Intensive Care Med       Date:  2022-07       Impact factor: 41.787

2.  Peer review: Troubled from the start.

Authors:  Alex Csiszar
Journal:  Nature       Date:  2016-04-21       Impact factor: 49.962

3.  Multistakeholder social media peer review and fixing slips.

Authors:  Daniele Poole; Audrey De Jong; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2022-06-02       Impact factor: 41.787

4.  Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia.

Authors:  Emily A Siegrist; Joseph Sassine
Journal:  Intensive Care Med       Date:  2022-05-26       Impact factor: 41.787

Review 5.  Reimagining the peer-review system for translational health science journals.

Authors:  Elise M Smith
Journal:  Clin Transl Sci       Date:  2021-05-07       Impact factor: 4.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.